1.Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls.
Joo Hyun LEE ; Hae Sook SOHN ; Jin Ho CHUN ; Hyoun Ah KIM ; Chang Hee SUH ; Yun Woo LEE ; Bo Young YOON
The Korean Journal of Internal Medicine 2014;29(1):76-84
BACKGROUND/AIMS: We investigated the agreement between the QuantiFERON-TB Gold (QFT-Gold) test and the tuberculin skin test (TST) in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis (RA), compared with healthy controls, in Korea. METHODS: We recruited 64 patients with RA and 79 healthy controls at two university hospitals in South Korea. The participants underwent both the QFT-Gold test and the TST simultaneously between August 2006 and February 2009. All patients were diagnosed using the classification criteria for RA revised in 1987 by the American College of Rheumatology. Bacillus Calmette-Guerin vaccination status and current medications were evaluated, and disease activities were assessed using the Disease Activity Score in 28 joints. Eleven patients with RA produced indeterminate QFT-Gold test results and were thus excluded from the kappa analysis. RESULTS: Based on an induration of 10 mm in diameter as the TST cutoff value, the QFT-Gold test and TST demonstrated 75.0% agreement (kappa = 0.23) in patients with RA and 75.9% agreement (kappa = 0.19) in healthy controls. Among the 56 patients with RA who had negative TST results, 11 patients (17.2%) also yielded indeterminate QFT-Gold results. CONCLUSIONS: Our study showed poor agreement between the results of the QFT-Gold test and the TST in both RA patients and healthy controls. Based on these findings, we emphasize the importance of making clinical decisions in the diagnosis of latent tuberculosis in Koreans with or without RA.
Adult
;
Aged
;
Arthritis, Rheumatoid/*complications
;
Female
;
Healthy Volunteers
;
Humans
;
Interferon-gamma Release Tests/*statistics & numerical data
;
Latent Tuberculosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Tuberculin Test/*statistics & numerical data
2.Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents.
Kyeong Hee KIM ; Sung Won LEE ; Won Tae CHUNG ; Byoung Gwon KIM ; Kwang Sook WOO ; Jin Yeong HAN ; Jeong Man KIM
The Korean Journal of Laboratory Medicine 2011;31(4):271-278
BACKGROUND: We assessed the efficacy of serial interferon-gamma release assays (IGRAs) for the diagnosis of latent tuberculosis infection (LTBI) in patients receiving immunosuppressive agents for treatment of rheumatic diseases in Korea. METHODS: Of 276 patients who underwent consecutive screening with one of two IGRAs [QuantiFERON-TB Gold or QuantiFERON-TB Gold In-Tube], 66 patients were evaluated by the serial IGRA for detection of LTBI during therapy with immunosuppressive agents. Information on clinical diagnosis, medication, previous TB, blood cell count, tuberculin skin test, and interferon-gamma (IFN-gamma) level measured by IGRA was collected. RESULTS: Of the 66 patients, the initial IGRA was positive in 24.2%, negative in 65.2%, and indeterminate in 10.6%. Forty-six patients (69.7%) showed consistent IGRA results during follow-up, and 13 patients (19.7%) had consistently positive results. IGRA conversion rate was 12.1% (8/66) and reversion rate was 4.5% (3/66). Conversion of IGRA results was only observed in ankylosing spondylitis patients, and the median interval between the two tests in patients with conversion was 8.5 months. The mean IFN-gamma level in the group of patients with consistently positive IGRA results was higher than that in the group with inconsistently positive results, although this trend was not statistically significant (P=0.293). Indeterminate results were observed most frequently in patients with systemic lupus erythematosus. CONCLUSIONS: In patients receiving immunosuppressive agents, both IGRA conversions and reversions were observed. Serial IGRA testing may not be needed in patients with a positive initial IGRA result showing high IFN-gamma levels, because of high consistency in the test results.
Adult
;
Blood Cell Count
;
Female
;
Follow-Up Studies
;
Humans
;
Immunosuppressive Agents/*therapeutic use
;
Interferon-gamma/*analysis
;
*Interferon-gamma Release Tests
;
Latent Tuberculosis/complications/*diagnosis/metabolism
;
Lupus Erythematosus, Systemic/complications/diagnosis/metabolism
;
Male
;
Middle Aged
;
Rheumatic Diseases/complications/diagnosis/drug therapy
;
Spondylitis, Ankylosing/complications/diagnosis/metabolism
;
Tuberculin Test
3.Impact of Parenchymal Tuberculosis Sequelae on Mediastinal Lymph Node Staging in Patients with Lung Cancer.
Seung Heon LEE ; Joo Won MIN ; Chang Hoon LEE ; Chang Min PARK ; Jin Mo GOO ; Doo Hyun CHUNG ; Chang Hyun KANG ; Young Tae KIM ; Young Whan KIM ; Sung Koo HAN ; Young Soo SHIM ; Jae Joon YIM
Journal of Korean Medical Science 2011;26(1):67-70
Because tuberculous (TB) involvement of mediastinal lymph nodes (LN) could cause false positive results in nodal staging of lung cancer, we examined the accuracy of nodal staging in lung cancer patients with radiographic sequelae of healed TB. A total of 54 lung cancer patients with radiographic TB sequelae in the lung parenchyma ipsilateral to the resected lung, who had undergone at least ipsilateral 4- and 7-lymph node dissection after both chest computed tomography (CT) and fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT were included for the analysis. The median age of 54 subjects was 66 yr and 48 were males. Calcified nodules and fibrotic changes were the most common forms of healed parenchymal pulmonary TB. Enlarged mediastinal lymph nodes (short diameter > 1 cm) were identified in 21 patients and positive mediastinal lymph nodes were identified using FDG-PET/CT in 19 patients. The overall sensitivity and specificity for mediastinal node metastasis were 60.0% and 69.2% with CT and 46.7% and 69.2% with FDG-PET/CT, respectively. In conclusion, the accuracy of nodal staging using CT or FDG-PET/CT might be low in lung cancer patients with parenchymal TB sequelae, because of inactive TB lymph nodes without viable TB bacilli.
Aged
;
Aged, 80 and over
;
Female
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Latent Tuberculosis/*complications/pathology
;
Lung Neoplasms/complications/*diagnosis/pathology
;
Lymph Nodes/pathology
;
Lymphatic Metastasis
;
Male
;
Mediastinum
;
Middle Aged
;
Neoplasm Staging
;
Positron-Emission Tomography
;
Predictive Value of Tests
;
Radiopharmaceuticals/diagnostic use
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed
4.Impact of Parenchymal Tuberculosis Sequelae on Mediastinal Lymph Node Staging in Patients with Lung Cancer.
Seung Heon LEE ; Joo Won MIN ; Chang Hoon LEE ; Chang Min PARK ; Jin Mo GOO ; Doo Hyun CHUNG ; Chang Hyun KANG ; Young Tae KIM ; Young Whan KIM ; Sung Koo HAN ; Young Soo SHIM ; Jae Joon YIM
Journal of Korean Medical Science 2011;26(1):67-70
Because tuberculous (TB) involvement of mediastinal lymph nodes (LN) could cause false positive results in nodal staging of lung cancer, we examined the accuracy of nodal staging in lung cancer patients with radiographic sequelae of healed TB. A total of 54 lung cancer patients with radiographic TB sequelae in the lung parenchyma ipsilateral to the resected lung, who had undergone at least ipsilateral 4- and 7-lymph node dissection after both chest computed tomography (CT) and fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT were included for the analysis. The median age of 54 subjects was 66 yr and 48 were males. Calcified nodules and fibrotic changes were the most common forms of healed parenchymal pulmonary TB. Enlarged mediastinal lymph nodes (short diameter > 1 cm) were identified in 21 patients and positive mediastinal lymph nodes were identified using FDG-PET/CT in 19 patients. The overall sensitivity and specificity for mediastinal node metastasis were 60.0% and 69.2% with CT and 46.7% and 69.2% with FDG-PET/CT, respectively. In conclusion, the accuracy of nodal staging using CT or FDG-PET/CT might be low in lung cancer patients with parenchymal TB sequelae, because of inactive TB lymph nodes without viable TB bacilli.
Aged
;
Aged, 80 and over
;
Female
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Latent Tuberculosis/*complications/pathology
;
Lung Neoplasms/complications/*diagnosis/pathology
;
Lymph Nodes/pathology
;
Lymphatic Metastasis
;
Male
;
Mediastinum
;
Middle Aged
;
Neoplasm Staging
;
Positron-Emission Tomography
;
Predictive Value of Tests
;
Radiopharmaceuticals/diagnostic use
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed